Dr. Olivier Blondel
DIVISION OF DIABETES, ENDOCRINOLOGY, & METABOLIC DISEASES
NIDDK, National Institutes of Health
Building 2DEM, Room 796
6707 Democracy Blvd.
Bethesda, MD 20817
Director, Endocrine Systems Biology Program
Grant portfolios: Endocrine Signaling, Stem Cell Research, Genomics Research, Systems Biology and Chemical Biology in the context of Diabetes, Obesity and Metabolic Diseases.
Administrative leadership (director) of the Beta Cell Biology Consortium (BCBC), a large international effort bringing a team-based approach to the acquisition of new knowledge and the production of new resources necessary to develop a cell-based therapy for insulin delivery. NIDDK contact person for matters relating to Regenerative Medicine.
Previous Training and Experience:
Ph.D., University of Paris 7, France (1986-1989)
Research during military service, CNRS UPR 9078, Meudon, France (1989-1990)
Postdoctoral Fellow, University of Chicago (1990-1994)
Research Associate, INSERM U-446, Chatenay-Malabry, France (1994-1997)
Visiting Scientist, NINDS/NIH, Bethesda, MD (1997-2000)Senior Scientist, Human Genome Sciences, Rockville MD (2001-2004)
Committees/ Working Groups:
Beta Cell, Adipocyte and Metabolism Working Group (BAM)
Type-1 Diabetes Working Group
Genomics/Genetics/ Bioinformatics Working Group
Obesity Research Working GroupNIDDK representative: Regenerative Medicine
Page last updated: January 01, 0001